UCB S.A.

SMYRNA, GA · CIK 0001290640 · Biotech · Public

Biopharmaceutical therapies for neurological and autoimmune diseases

ucb.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$788K
1 Form D · May 2015
137 months since last filing
Contracts
—
No federal contracts on record
Patents
5
0 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$787,628
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1435BIOLIFE SOLUTIONS INC—$10M
1436TransChromix LLC——
1437ENTERX BIOSCIENCES, INC.——
1438UCB S.A.—$788K
1439SIWA Biotech Corp.—$8.7M
1440ARTBIO——
1441KJ BIOSCIENCES, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 15 related persons
  • Kay DaviesDirector
  • Albrecht De GraeveDirector
  • Arnoud de PretDirector
  • Evelyn du MonceauDirector
  • Ctesse du Monceau de BergendalExecutive Officer
  • Harriet EdelmanDirector
  • Charles-Antoine JanssenDirector
  • Jean-Pierre KinetDirector
  • Gerhard MayrDirector · Executive Officer
  • Tom McKillopDirector
  • Norman OrsteinDirector
  • Jean-Christophe TellierDirector · Executive Officer
  • Cedric van RijckevorselDirector
  • Jeffrey WrenExecutive Officer
  • Michel XavierExecutive Officer

Patents

USPTO · 0 granted of 5
  • Multiple Active Drug-resin Conjugateapplication
  • Removable Pressure Sensitive Adhesives With Plasticizer Resistance Propertiesapplication
  • Methods For The Identification Of Agents For The Treatment Of Seizures Neurological Diseases Endocrinopathies And Hormonal Diseasesapplication
  • Waterfast Ink Jet Inks Containing A Uv Curable Resinapplication
  • Novel Genes Associated With Allergic Hypersensitivity And Mast Cell Avctivationapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.